Jones Trading analyst Justin Walsh downgraded BioLineRx (NASDAQ: BLRX) from Buy to Hold.The analyst comments "What's new. On 3/31/2025, BioLineRx ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE